0001706524 false 2021 --12-31 Q3 0001706524 2021-01-01 2021-09-30 0001706524 2021-11-05 0001706524 2021-09-30 0001706524 2020-12-31 0001706524 2021-07-01 2021-09-30 0001706524 2020-07-01 2020-09-30 0001706524 2020-01-01 2020-09-30 0001706524 UGRO:EquipmentSystemsMember 2021-07-01 2021-09-30 0001706524 UGRO:EquipmentSystemsMember 2020-07-01 2020-09-30 0001706524 UGRO:EquipmentSystemsMember 2021-01-01 2021-09-30 0001706524 UGRO:EquipmentSystemsMember 2020-01-01 2020-09-30 0001706524 UGRO:ServicesMember 2021-07-01 2021-09-30 0001706524 UGRO:ServicesMember 2020-07-01 2020-09-30 0001706524 UGRO:ServicesMember 2021-01-01 2021-09-30 0001706524 UGRO:ServicesMember 2020-01-01 2020-09-30 0001706524 UGRO:ConsumableProductsMember 2021-07-01 2021-09-30 0001706524 UGRO:ConsumableProductsMember 2020-07-01 2020-09-30 0001706524 UGRO:ConsumableProductsMember 2021-01-01 2021-09-30 0001706524 UGRO:ConsumableProductsMember 2020-01-01 2020-09-30 0001706524 us-gaap:CommonStockMember 2021-06-30 0001706524 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001706524 us-gaap:RetainedEarningsMember 2021-06-30 0001706524 us-gaap:TreasuryStockMember 2021-06-30 0001706524 2021-06-30 0001706524 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001706524 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001706524 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001706524 us-gaap:TreasuryStockMember 2021-07-01 2021-09-30 0001706524 us-gaap:CommonStockMember 2021-09-30 0001706524 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001706524 us-gaap:RetainedEarningsMember 2021-09-30 0001706524 us-gaap:TreasuryStockMember 2021-09-30 0001706524 us-gaap:CommonStockMember 2020-06-30 0001706524 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001706524 us-gaap:RetainedEarningsMember 2020-06-30 0001706524 us-gaap:TreasuryStockMember 2020-06-30 0001706524 2020-06-30 0001706524 us-gaap:CommonStockMember 2020-07-01 2020-09-30 0001706524 us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2020-09-30 0001706524 us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 0001706524 us-gaap:TreasuryStockMember 2020-07-01 2020-09-30 0001706524 us-gaap:CommonStockMember 2020-09-30 0001706524 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001706524 us-gaap:RetainedEarningsMember 2020-09-30 0001706524 us-gaap:TreasuryStockMember 2020-09-30 0001706524 2020-09-30 0001706524 us-gaap:CommonStockMember 2020-12-31 0001706524 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001706524 us-gaap:RetainedEarningsMember 2020-12-31 0001706524 us-gaap:TreasuryStockMember 2020-12-31 0001706524 us-gaap:CommonStockMember 2021-01-01 2021-09-30 0001706524 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-09-30 0001706524 us-gaap:RetainedEarningsMember 2021-01-01 2021-09-30 0001706524 us-gaap:TreasuryStockMember 2021-01-01 2021-09-30 0001706524 us-gaap:CommonStockMember 2019-12-31 0001706524 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001706524 us-gaap:RetainedEarningsMember 2019-12-31 0001706524 us-gaap:TreasuryStockMember 2019-12-31 0001706524 2019-12-31 0001706524 us-gaap:CommonStockMember 2020-01-01 2020-09-30 0001706524 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-09-30 0001706524 us-gaap:RetainedEarningsMember 2020-01-01 2020-09-30 0001706524 us-gaap:TreasuryStockMember 2020-01-01 2020-09-30 0001706524 UGRO:PurchaseAgreementMember 2021-06-27 2021-06-28 0001706524 UGRO:PurchaseAgreementMember 2021-06-28 0001706524 UGRO:TargetCompaniesMember 2021-06-27 2021-06-28 0001706524 UGRO:TargetCompaniesMember 2021-06-28 0001706524 2020-12-29 2020-12-31 0001706524 UGRO:Cloud9SupportMember 2021-01-01 2021-09-30 0001706524 UGRO:Cloud9SupportMember 2020-01-01 2020-09-30 0001706524 UGRO:Cloud9SupportMember 2021-07-01 2021-09-30 0001706524 UGRO:Cloud9SupportMember 2020-07-01 2020-09-30 0001706524 UGRO:Cloud9SupportMember 2021-09-30 0001706524 UGRO:Cloud9SupportMember 2020-12-31 0001706524 us-gaap:UnsecuredDebtMember UGRO:JamesLoweMember 2018-10-31 0001706524 us-gaap:UnsecuredDebtMember UGRO:JamesLoweMember 2018-10-01 2018-10-31 0001706524 UGRO:JamesLoweMember 2018-10-01 2018-10-31 0001706524 UGRO:JamesLoweMember 2018-10-31 0001706524 us-gaap:UnsecuredDebtMember UGRO:JamesLoweMember 2019-05-01 2019-12-31 0001706524 UGRO:JamesLoweMember us-gaap:CommonStockMember 2019-05-01 2019-12-31 0001706524 UGRO:JamesLoweMember us-gaap:CommonStockMember 2020-02-23 2020-02-25 0001706524 UGRO:BridgeFinancingMember UGRO:JamesLoweMember 2020-12-13 2020-12-15 0001706524 UGRO:BridgeFinancingMember UGRO:JamesLoweMember 2020-12-15 0001706524 us-gaap:CustomerRelationshipsMember 2021-09-30 0001706524 us-gaap:TrademarksAndTradeNamesMember 2021-09-30 0001706524 us-gaap:OtherIntangibleAssetsMember 2021-09-30 0001706524 us-gaap:OtherIntangibleAssetsMember 2020-12-31 0001706524 us-gaap:ConvertibleDebtMember 2021-09-30 0001706524 UGRO:PaycheckProtectionProgramLoanPayableMember 2020-12-31 0001706524 UGRO:PaycheckProtectionProgramLoanPayableMember 2021-09-30 0001706524 us-gaap:ConvertibleDebtMember 2020-12-31 0001706524 UGRO:BridgeFinancingNotesMember 2020-12-31 0001706524 UGRO:JamesLoweMember 2020-12-31 0001706524 UGRO:BridgeFinancingNotesMember 2020-11-01 2020-11-30 0001706524 UGRO:BridgeFinancingNotesMember 2020-12-01 2020-12-31 0001706524 UGRO:BridgeFinancingNotesMember 2020-10-01 2020-12-31 0001706524 UGRO:QualifiedOfferingMember 2020-12-31 0001706524 us-gaap:RevolvingCreditFacilityMember 2021-09-30 0001706524 us-gaap:RevolvingCreditFacilityMember 2020-12-31 0001706524 UGRO:TermLoanMember 2021-09-30 0001706524 UGRO:TermLoanMember 2020-12-31 0001706524 UGRO:CreditAgreementMember 2020-02-20 2020-02-21 0001706524 us-gaap:RevolvingCreditFacilityMember UGRO:CreditAgreementMember 2020-02-21 0001706524 UGRO:TermLoanMember UGRO:CreditAgreementMember 2020-02-21 0001706524 us-gaap:RevolvingCreditFacilityMember UGRO:CreditAgreementMember 2020-02-20 2020-02-21 0001706524 UGRO:CreditAgreementMember us-gaap:PrimeRateMember 2020-09-03 2020-09-04 0001706524 UGRO:TermLoanMember UGRO:CreditAgreementMember 2021-01-30 2021-01-31 0001706524 UGRO:TermLoanMember UGRO:CreditAgreementMember 2021-02-27 2021-03-01 0001706524 us-gaap:RevolvingCreditFacilityMember UGRO:CreditAgreementMember 2020-09-29 2020-10-02 0001706524 us-gaap:RevolvingCreditFacilityMember UGRO:CreditAgreementMember 2020-09-04 0001706524 us-gaap:RevolvingCreditFacilityMember UGRO:CommonStockAndWarrantMember UGRO:CreditAgreementMember 2020-09-04 0001706524 us-gaap:MeasurementInputSharePriceMember UGRO:CreditAgreementMember 2020-09-04 0001706524 UGRO:CreditAgreementMember 2020-09-04 0001706524 us-gaap:MeasurementInputRiskFreeInterestRateMember UGRO:CreditAgreementMember 2020-09-04 0001706524 us-gaap:MeasurementInputPriceVolatilityMember UGRO:CreditAgreementMember 2020-09-04 0001706524 us-gaap:RevolvingCreditFacilityMember UGRO:CreditAgreementMember 2020-12-31 0001706524 UGRO:TermLoanMember UGRO:CreditAgreementMember 2020-12-31 0001706524 UGRO:OneClientMember us-gaap:RevenueFromContractWithCustomerMember UGRO:ClientConcentrationRiskMember 2021-01-01 2021-09-30 0001706524 UGRO:SeparateClientMember us-gaap:RevenueFromContractWithCustomerMember UGRO:ClientConcentrationRiskMember 2020-01-01 2020-09-30 0001706524 UGRO:OneClientMember us-gaap:RevenueFromContractWithCustomerMember UGRO:ClientConcentrationRiskMember 2021-07-01 2021-09-30 0001706524 UGRO:SeparateClientMember us-gaap:RevenueFromContractWithCustomerMember UGRO:ClientConcentrationRiskMember 2021-07-01 2021-09-30 0001706524 UGRO:OneClientMember us-gaap:AccountsReceivableMember UGRO:ClientConcentrationRiskMember 2021-01-01 2021-09-30 0001706524 UGRO:OneClientMember us-gaap:AccountsReceivableMember UGRO:ClientConcentrationRiskMember 2020-01-01 2020-12-31 0001706524 UGRO:SeparateClientMember us-gaap:AccountsReceivableMember UGRO:ClientConcentrationRiskMember 2020-01-01 2020-12-31 0001706524 UGRO:OneVendorMember UGRO:PurchasesMember UGRO:VendorConcentrationRiskMember 2021-01-01 2021-09-30 0001706524 UGRO:OneVendorMember UGRO:PurchasesMember UGRO:VendorConcentrationRiskMember 2020-01-01 2020-09-30 0001706524 UGRO:OneVendorMember UGRO:PurchasesMember UGRO:VendorConcentrationRiskMember 2021-07-01 2021-09-30 0001706524 UGRO:OneSeparateVendorMember UGRO:PurchasesMember UGRO:VendorConcentrationRiskMember 2020-07-01 2020-09-30 0001706524 UGRO:OneVendorMember us-gaap:AccountsPayableMember UGRO:VendorConcentrationRiskMember 2021-01-01 2021-09-30 0001706524 UGRO:OneSeparateVendorMember us-gaap:AccountsPayableMember UGRO:VendorConcentrationRiskMember 2020-01-01 2020-12-31 0001706524 2020-01-01 2020-12-31 0001706524 us-gaap:EmployeeStockOptionMember 2021-09-30 0001706524 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-09-30 0001706524 2020-03-01 2020-03-31 0001706524 2021-02-16 2021-02-17 0001706524 2021-02-17 0001706524 UGRO:BoardOfDirectorsMember 2021-05-22 2021-05-24 0001706524 us-gaap:WarrantMember 2020-12-31 0001706524 us-gaap:WarrantMember 2021-01-01 2021-09-30 0001706524 us-gaap:WarrantMember 2021-09-30 0001706524 us-gaap:MeasurementInputSharePriceMember 2021-09-30 0001706524 UGRO:MeasurementInputContractualTermMember 2021-09-30 0001706524 us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-09-30 0001706524 us-gaap:MeasurementInputPriceVolatilityMember 2021-09-30 0001706524 us-gaap:SubsequentEventMember UGRO:ThirdPartyMember 2021-10-11 2021-10-13 0001706524 us-gaap:SubsequentEventMember 2021-10-11 2021-10-13 0001706524 us-gaap:SubsequentEventMember UGRO:XSFMember 2021-11-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure iso4217:CAD

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2021

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _________ to _________.

Commission File Number: 001-39933

urban-gro, Inc.

(Exact name of registrant as specified in its charter)

Delaware |  | 46-5158469
(State or other jurisdiction of incorporation or organization) |  | (I.R.S. Employer Identification No.)

1751 Panorama Point, Unit G Lafayette, CO |  | 80026
(Address of principal executive offices) |  | (Zip Code)

(720) 390-3880

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act: None

Title of each class |  | Trading Symbol(s) |  | Name of each exchange on which registered
Common Stock, $0.001 par value |  | UGRO |  | NASDAQ

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ | Accelerated filer ☐
Non-accelerated filer ☒ | Smaller reporting company ☒
| Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

The number of shares of the registrant’s only class of common stock outstanding as of November 5, 2021 was 10,759,820 shares.

urban gro, Inc.

FORM 10-Q

For the Quarterly Period Ended September 30, 2021

INDEX

|  | Page
| PART I. FINANCIAL INFORMATION |
Item 1. | Financial Statements (Unaudited) | 4
| Unaudited Condensed Consolidated Balance Sheets | 4
| Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) | 5
| Unaudited Condensed Consolidated Statements of Shareholders’ Equity (Deficit) | 6
| Unaudited Condensed Consolidated Statements of Cash Flows | 8
| Notes to Unaudited Condensed Consolidated Financial Statements | 9
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 15
Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 18
Item 4. | Controls and Procedures | 18
| PART II. OTHER INFORMATION |
Item 1. | Legal Proceedings | 19
Item 1A. | Risk Factors | 19
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 19
Item 3. | Defaults Upon Senior Securities | 19
Item 4. | Mine Safety Disclosures | 19
Item 5. | Other Information | 19
Item 6. | Exhibits | 19
Signatures | 20

2

FORWARD LOOKING STATEMENTS

This Report on Form 10-Q (the “Report”) contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward looking statements are statements not based on historical information and which relate to future operations, strategies, financial results or other developments. The statements regarding urban-gro, Inc. contained in this Report that are not historical in nature, particularly those that utilize terminology such as “may,” “will,” “should,” “likely,” “expects,” “anticipates,” “estimates,” “believes” or “plans,” or comparable terminology, are forward-looking statements based on current expectations and assumptions that are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond our control and many of which, with respect to future business decisions, are subject to change. These uncertainties and contingencies can affect actual results and could cause actual results to differ materially from those expressed in any forward-looking statements made by, or on our behalf. We caution readers regarding certain forward-looking statements in this Report and in any other statement made by, or on our behalf, whether or not in future filings with the Securities and Exchange Commission (the “SEC”).

Important factors known to us that could cause such material differences are identified in this Report, including the factors described in Part I, Item 1A, Risk Factors, of our Annual Report on Form 10-K for the year ended December 31, 2020. Except as required by applicable law, we undertake no obligation to correct or update any forward-looking statements, whether as a result of new information, future events or otherwise. You are advised, however, to consult any future disclosures we make on related subjects in future reports to the SEC.

3

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

urban-gro, Inc.

CONDENSED CONSOLIDATED BALANCE SHEETS

(unaudited)

|  | September 30, 2021 |  |  | December 31, 2020 |
Assets |  |  |  |  |  |  |  |
Current assets: |  |  |  |  |  |  |  |
Cash |  | $ | 40,515,927 |  |  | $ | 184,469 |
Accounts receivable, net |  |  | 5,764,361 |  |  |  | 915,052 |
Inventories |  |  | 604,413 |  |  |  | 537,104 |
Related party receivable |  |  | 10,975 |  |  |  | 61,678 |
Prepayments and other assets |  |  | 7,790,637 |  |  |  | 3,547,068 |
Total current assets |  |  | 54,686,313 |  |  |  | 5,245,371 |
Non-current assets: |  |  |  |  |  |  |  |
Property and equipment, net |  |  | 220,300 |  |  |  | 129,444 |
Operating lease right of use assets, net |  |  | 721,614 |  |  |  | 88,889 |
Investments |  |  | 1,710,358 |  |  |  | 1,710,358 |
Goodwill |  |  | 8,893,047 |  |  |  | 902,067 |
Intangible assets, net |  |  | 1,745,787 |  |  |  | 84,514 |
Total non-current assets |  |  | 13,291,106 |  |  |  | 2,915,272 |
Total assets |  | $ | 67,977,419 |  |  | $ | 8,160,643 |
Liabilities |  |  |  |  |  |  |  |
Current liabilities: |  |  |  |  |  |  |  |
Accounts payable |  | $ | 2,778,183 |  |  | $ | 653,998 |
Accrued expenses |  |  | 4,265,839 |  |  |  | 1,798,494 |
Deposits |  |  | 9,396,595 |  |  |  | 4,878,863 |
Contingent consideration |  |  | 1,563,000 |  |  |  | - |
Notes payable |  |  | - |  |  |  | 1,854,500 |
Revolving Facility |  |  | - |  |  |  | 3,403,143 |
Term Loan, net |  |  | - |  |  |  | 1,868,320 |
Operating lease liabilities |  |  | 152,459 |  |  |  | 88,889 |
Total current liabilities |  |  | 18,156,076 |  |  |  | 14,546,207 |
Non-current liabilities: |  |  |  |  |  |  |  |
Notes payable |  |  | - |  |  |  | 1,020,600 |
Operating lease liabilities |  |  | 570,345 |  |  |  | - |
Deferred tax liability |  |  | 440,750 |  |  |  |  |
Total non-current liabilities |  |  | 1,011,095 |  |  |  | 1,020,600 |
Total liabilities |  |  | 19,167,171 |  |  |  | 15,566,807 |
Shareholders’ equity (deficit): |  |  |  |  |  |  |  |
Preferred stock, $0.10 par value; 10,000,000 shares authorized; 0 shares issued and outstanding |  |  | - |  |  |  | – |
Common stock, $0.001 par value; 100,000,000 shares authorized; 11,530,844 issued and 10,759,820 outstanding as of September 30, 2021, and 4,718,714 shares issued and outstanding as of December 31, 2020 |  |  | 11,530 |  |  |  | 4,719 |
Additional paid in capital |  |  | 77,936,332 |  |  |  | 14,553,438 |
Treasury shares, cost basis: 771,024 shares as of September 30, 2021 |  |  | (6,901,811 | ) |  |  | - |
Accumulated deficit |  |  | (22,235,803 | ) |  |  | (21,964,321 | )
Total shareholders’ equity (deficit) |  |  | 48,810,248 |  |  |  | (7,406,164 | )
Total liabilities and shareholders’ equity (deficit) |  | $ | 67,977,419 |  |  | $ | 8,160,643 |

See accompanying notes to unaudited condensed consolidated financial statements

4

urban-gro, Inc.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

(unaudited)

|  | Three Months Ended September 30, |  |  | Nine Months Ended September 30, |
|  | 2021 |  |  | 2020 |  |  | 2021 |  |  | 2020 |
Revenue |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Equipment systems |  | $ | 16,454,321 |  |  | $ | 7,431,693 |  |  | $ | 39,978,388 |  |  | $ | 13,723,868 |
Services |  |  | 1,461,041 |  |  |  | 448,882 |  |  |  | 2,009,961 |  |  |  | 1,490,216 |
Consumable products |  |  | 372,449 |  |  |  | 478,847 |  |  |  | 1,165,115 |  |  |  | 1,411,604 |
Total Revenue |  |  | 18,287,811 |  |  |  | 8,359,422 |  |  |  | 43,153,464 |  |  |  | 16,625,688 |
Cost of Revenue |  |  | 14,029,677 |  |  |  | 6,654,134 |  |  |  | 33,332,303 |  |  |  | 12,613,461 |
Gross profit |  |  | 4,258,134 |  |  |  | 1,705,288 |  |  |  | 9,821,161 |  |  |  | 4,012,227 |
Operating expenses: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
General and administrative |  |  | 3,685,396 |  |  |  | 1,454,570 |  |  |  | 8,283,233 |  |  |  | 5,110,476 |
Stock-based compensation |  |  | 506,034 |  |  |  | 399,258 |  |  |  | 1,096,441 |  |  |  | 1,391,807 |
Total operating expenses |  |  | 4,191,430 |  |  |  | 1,853,828 |  |  |  | 9,379,674 |  |  |  | 6,502,283 |
Income (loss) from operations |  |  | 66,704 |  |  |  | (148,540 | ) |  |  | 441,487 |  |  |  | (2,490,056 | )
Non-operating income (expenses): |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Interest expense |  |  | (4,331 | ) |  |  | (393,158 | ) |  |  | (326,397 | ) |  |  | (1,057,501 | )
Interest expense – beneficial conversion of notes payable |  |  | - |  |  |  | - |  |  |  | (636,075 | ) |  |  | - |
Loss on extinguishment of debt |  |  | - |  |  |  | - |  |  |  | (790,723 | ) |  |  | - |
Contingent consideration |  |  | - |  |  |  | (155,000 | ) |  |  | - |  |  |  | (155,000 | )
Impairment of investment |  |  | - |  |  |  | - |  |  |  | - |  |  |  | (310,000 | )
PPP Loan Forgiveness |  |  | - |  |  |  | - |  |  |  | 1,032,316 |  |  |  | - |
Other income |  |  | (2,717 | ) |  |  | 2,417 |  |  |  | 7,910 |  |  |  | 52,675 |
Total non-operating income (expenses) |  |  | (7,048 | ) |  |  | (545,741 | ) |  |  | (712,969 | ) |  |  | (1,469,826 | )
Income (loss) before income taxes |  |  | 59,656 |  |  |  | (694,281 | ) |  |  | (271,482 | ) |  |  | (3,959,882 | )
Income tax expense (benefit) |  |  | - |  |  |  | – |  |  |  | - |  |  |  | – |
Net income (loss) |  | $ | 59,656 |  |  | $ | (694,281 | ) |  | $ | (271,482 | ) |  | $ | (3,959,882 | )
Comprehensive income (loss) |  | $ | 59,656 |  |  | $ | (694,281 | ) |  | $ | (271,482 | ) |  | $ | (3,959,882 | )
Earnings (loss) per share: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Earnings (loss) per share - basic |  | $ | 0.01 |  |  | $ | (0.14 | ) |  | $ | (0.03 | ) |  | $ | (0.83 | )
Earnings (loss) per share - dilutive |  | $ | 0.00 |  |  | $ | (0.14 | ) |  | $ | (0.03 | ) |  | $ | (0.83 | )
Weighted average share - basic |  |  | 11,440,255 |  |  |  | 4,814,699 |  |  |  | 10,177,482 |  |  |  | 4,784,484 |
Weighted average shares - dilutive |  |  | 12,204,530 |  |  |  | 4,814,699 |  |  |  | 10,177,482 |  |  |  | 4,784,484 |

See accompanying notes to unaudited condensed consolidated financial statements

5

urban-gro, Inc.

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY (DEFICIT)

(unaudited)

|  | Common Stock |  |  | Additional Paid in |  |  | Accumulated |  |  | Treasury |  |  | Total Shareholders’ Equity |
|  | Shares |  |  | Amount |  |  | Capital |  |  | Deficit |  |  | Stock |  |  | (Deficit) |
Balance, June 30, 2021 |  |  | 11,222,914 |  |  | $ | 11,223 |  |  |  | 75,227,775 |  |  | $ | (22,295,459 | ) |  | $ | (3,474,270 | ) |  | $ | 49,469,269 |
Stock-based compensation |  |  | - |  |  |  | - |  |  |  | 506,034 |  |  |  | - |  |  |  | - |  |  |  | 506,034 |
Stock grant to satisfy accounts payable |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock grant to satisfy accounts payable, shares |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
beneficial conversion feature |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Conversion of Bridge Financing |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Conversion of Bridge Financing, shares |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock grant to satisfy accounts payable |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock grant to satisfy accounts payable,shares |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock issuance related to acquisition |  |  | 202,066 |  |  |  | 202 |  |  |  | 1,999,798 |  |  |  | - |  |  |  | - |  |  |  | 2,000,000 |
Clawback of stock granted |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Clawback of stock granted,shares |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock issuance related to debt |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock issuance related to debt, shares |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock repurchased |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | (3,427,541 | ) |  |  | (3,427,541 | )
Stock issued with exercise of warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock issued with exercise of warrants, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock issued in conversion of warrants |  |  | 4,078 |  |  |  | 4 |  |  |  | (4 | ) |  |  | - |  |  |  | - |  |  |  | - |
Stock issuance related to loan term revisions |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock issuance related to loan term revisions, shares |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock grant program vesting |  |  | 68,681 |  |  |  | 68 |  |  |  | (68 | ) |  |  | - |  |  |  | - |  |  |  | - |
Stock issuance related to offering,net of offering costs |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock issuance related to offering, net of offering costs, shares |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock Options Exercised |  |  | 33,105 |  |  |  | 33 |  |  |  | 202,797 |  |  |  | - |  |  |  | - |  |  |  | 202,830 |
Warrant issuance related to debt |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock issued for lease revision |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock issued for lease revision, shares |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net income (loss) for period ended September 30, 2021 |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 59,656 |  |  |  | - |  |  |  | 59,656 |
Balance, September 30, 2021 |  |  | 11,530,844 |  |  | $ | 11,530 |  |  | $ | 77,936,332 |  |  | $ | (22,235,803 | ) |  | $ | (6,901,811 | ) |  | $ | 48,810,248 |

|  | Shares |  |  | Amount |  |  | Capital |  |  | Deficit |  |  | (Deficit) |
|  | Common Stock |  |  | Additional Paid in |  |  | Accumulated |  |  | Total Shareholders’ Equity |
|  | Shares |  |  | Amount |  |  | Capital |  |  | Deficit |  |  | (Deficit) |
Balance, June 30, 2020 |  |  | 4,805,163 |  |  | $ | 4,805 |  |  | $ | 13,546,858 |  |  | $ | (20,156,227 | ) | - | $ | (6,604,564 | )
Stock-based compensation |  |  | – |  |  |  | – |  |  |  | 399,258 |  |  |  | – |  | - |  | 399,258 |
Stock grant to satisfy accounts payable |  |  | 1,607 |  |  |  | 2 |  |  |  | 9,638 |  |  |  | – |  |  |  | 9,640 |
Stock grant program vesting |  |  | 21,945 |  |  |  | 22 |  |  |  | (22 | ) |  |  | – |  |  |  | – |
Stock issuance related to acquisition |  |  | 41,667 |  |  |  | 42 |  |  |  | 154,958 |  |  |  | – |  |  |  | 155,000 |
Clawback of stock granted |  |  | (166,667 | ) |  |  | (167 | ) |  |  | 167 |  |  |  | – |  |  |  | - |
Stock issued for lease revision |  |  | 8,333 |  |  |  | 8 |  |  |  | 30,992 |  |  |  | – |  |  |  | 31,000 |
Net income (loss) for period ended September 30, 2020 |  |  | – |  |  |  | – |  |  |  | – |  |  |  | (694,281 | ) |  |  | (694,281 | )
Balance, September 30, 2020 |  |  | 4,712,048 |  |  | $ | 4,712 |  |  | $ | 14,141,849 |  |  | $ | (20,850,508 | ) | - | $ | (6,703,947 | )

See accompanying notes to unaudited condensed consolidated financial statements

6

urban-gro, Inc.

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY (DEFICIT) (Continued)

(unaudited)

|  | Common Stock |  |  | Additional Paid in |  |  | Accumulated |  |  | Treasury |  |  | Total Shareholders’ Equity |
|  | Shares |  |  | Amount |  |  | Capital |  |  | Deficit |  |  | Stock |  |  | (Deficit) |
Balance, December 31, 2020 |  |  | 4,718,714 |  |  | $ | 4,719 |  |  | $ | 14,553,438 |  |  | $ | (21,964,321 | ) |  | $ | - |  |  | $ | (7,406,164 | )
Stock-based compensation |  |  | - |  |  |  | - |  |  |  | 1,096,441 |  |  |  | - |  |  |  | - |  |  |  | 1,096,441 |
Beneficial conversion feature |  |  | - |  |  |  | - |  |  |  | 636,075 |  |  |  | - |  |  |  | - |  |  |  | 636,075 |
Conversion of Bridge Financing |  |  | 254,425 |  |  |  | 254 |  |  |  | 1,907,971 |  |  |  | - |  |  |  | - |  |  |  | 1,908,225 |
Stock grant program vesting |  |  | 85,267 |  |  |  | 85 |  |  |  | (85 | ) |  |  | - |  |  |  | - |  |  |  | - |
Stock issuance related to offering, net of offering costs of $4,596,257 |  |  | 6,210,000 |  |  |  | 6,210 |  |  |  | 57,497,533 |  |  |  | - |  |  |  | - |  |  |  | 57,503,743 |
Stock issuance related to acquisition |  |  | 202,066 |  |  |  | 202 |  |  |  | 1,999,798 |  |  |  | - |  |  |  | - |  |  |  | 2,000,000 |
Common stock repurchased |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | (6,901,811 | ) |  |  | (6,901,811 | )
Stock issued with exercise of warrants |  |  | 22,490 |  |  |  | 22 |  |  |  | 9,974 |  |  |  | - |  |  |  | - |  |  |  | 9,996 |
Stock Options Exercised |  |  | 37,882 |  |  |  | 38 |  |  |  | 235,187 |  |  |  | - |  |  |  | - |  |  |  | 235,225 |
Net income (loss) for period ended September 30, 2021 |  |  | - |  |  |  | - |  |  |  | - |  |  |  | (271,482 | ) |  |  | - |  |  |  | (271,482 | )
Balance, September 30, 2021 |  |  | 11,530,844 |  |  | $ | 11,530 |  |  | $ | 77,936,332 |  |  | $ | (22,235,803 | ) |  | $ | (6,901,811 | ) |  | $ | 48,810,248 |

|  | Shares |  |  | Amount |  |  | Capital |  |  | Deficit |  |  | (Deficit) |
|  | Common Stock |  |  | Additional Paid in |  |  | Accumulated |  |  | Total Shareholders’ |
|  | Shares |  |  | Amount |  |  | Capital |  |  | Deficit |  |  | Deficit |
Balance, December 31, 2019 |  |  | 4,701,552 |  |  | $ | 4,702 |  |  | $ | 11,877,590 |  |  | $ | (16,890,626 | ) | - | $ | (5,008,334 | )
Stock-based compensation |  |  | – |  |  |  | – |  |  |  | 1,391,807 |  |  |  | – |  | - |  | 1,391,807 |
Stock grant to satisfy accounts payable |  |  | 1,607 |  |  |  | 2 |  |  |  | 9,638 |  |  |  |  |  |  |  | 9,640 |
Stock issuance related to loan term revisions |  |  | 16,667 |  |  |  | 16 |  |  |  | 99,984 |  |  |  | – |  |  |  | 100,000 |
Stock grant program vesting |  |  | 42,222 |  |  |  | 42 |  |  |  | (42 | ) |  |  | – |  |  |  | – |
Clawback of stock granted |  |  | (183,333 | ) |  |  | (183 | ) |  |  | 183 |  |  |  | – |  |  |  | – |
Stock issuance related to debt |  |  | 83,333 |  |  |  | 83 |  |  |  | 499,917 |  |  |  | – |  |  |  | 500,000 |
Stock issuance related to acquisition |  |  | 41,667 |  |  |  | 42 |  |  |  | 154,958 |  |  |  |  |  |  |  | 155,000 |
Warrant issuance related to debt |  |  | – |  |  |  | – |  |  |  | 76,822 |  |  |  | – |  |  |  | 76,822 |
Stock issued for lease revision |  |  | 8,333 |  |  |  | 8 |  |  |  | 30,992 |  |  |  |  |  |  |  | 31,000 |
Net income (loss) for period ended September 30, 2020 |  |  | – |  |  |  | – |  |  |  | – |  |  |  | (3,959,882 | ) |  |  | (3,959,882 | )
Balance, September 30, 2020 |  |  | 4,712,048 |  |  | $ | 4,712 |  |  | $ | 14,141,849 |  |  | $ | (20,850,508 | ) | - | $ | (6,703,947 | )

See accompanying notes to unaudited condensed consolidated financial statements

7

urban-gro, Inc.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited)

|  | Nine Months Ended September 30, |
|  | 2021 |  |  | 2020 |
Cash Flows from Operating Activities |  |  |  |  |  |  |  |
Net income (loss) |  | $ | (271,482 | ) |  | $ | (3,959,882 | )
Adjustments to reconcile net income (loss) from operations: |  |  |  |  |  |  |  |
Depreciation and amortization |  |  | 263,932 |  |  |  | 181,750 |
Amortization of deferred financing costs |  |  | 103,632 |  |  |  | 368,661 |
Loss on extinguishment of debt |  |  | 790,723 |  |  |  | – |
Interest on convertible notes |  |  | 53,725 |  |  |  | – |
Stock-based compensation expense |  |  | 1,096,441 |  |  |  | 1,391,807 |
Contingent consideration expense |  |  | - |  |  |  | 155,000 |
Beneficial conversion of Bridge notes |  |  | 636,075 |  |  |  | - |
Impairment of investment |  |  | - |  |  |  | 310,000 |
Gain on disposal of assets |  |  | - |  |  |  | 3,468 |
Inventory write-offs |  |  | 26,792 |  |  |  | 72,258 |
Bad debt expense |  |  | 28,248 |  |  |  | 43,849 |
PPP loan forgiveness |  |  | (1,032,316 | ) |  |  | – |
Changes in operating assets and liabilities (net of acquired amounts): |  |  |  |  |  |  |  |
Accounts receivable |  |  | (3,229,513 | ) |  |  | 658,706 |
Inventories |  |  | (94,101 | ) |  |  | (171,147 | )
Prepayments and other assets |  |  | (5,237,138 | ) |  |  | (784,210 | )
Accounts payable and accrued expenses |  |  | 2,672,135 |  |  |  | (2,470,559 | )
Deposits |  |  | 4,517,732 |  |  |  | 1,172,186 |
Net Cash Provided By (Used In) Operating Activities |  |  | 324,885 |  |  |  | (3,028,113 | )
Cash Flows from Investing Activities |  |  |  |  |  |  |  |
Business combinations, net of cash acquired |  |  | (5,551,642 | ) |  |  | - |
Purchases of property and equipment |  |  | (189,528 | ) |  |  | (122,817 | )
Net Cash Used In Investing Activities |  |  | (5,741,170 | ) |  |  | (122,817 | )
Cash Flows from Financing Activities |  |  |  |  |  |  |  |
Proceeds from issuance of Revolving Facility |  |  | - |  |  |  | 2,207,432 |
Proceeds from issuance of Term Loan |  |  | - |  |  |  | 2,000,000 |
Proceeds from Revolving Facility advances |  |  | - |  |  |  | 1,069,061 |
Proceeds from issuance of Common Stock, net of offering costs |  |  | 58,405,686 |  |  |  | – |
Repurchase of Common Stock |  |  | (6,901,811 | ) |  |  | – |
Long-term note payable |  |  | - |  |  |  | 1,020,600 |
Debt financing costs |  |  | - |  |  |  | (638,046 | )
Repayment of debt |  |  | (5,755,845 | ) |  |  | (2,743,428 | )
Net Cash Provided by Financing Activities |  |  | 45,748,030 |  |  |  | 2,915,619 |
Net Increase (Decrease) in Cash |  |  | 40,331,458 |  |  |  | (253,311 | )
Cash at Beginning of Period |  |  | 184,469 |  |  |  | 448,703 |
Cash at End of Period |  | $ | 40,515,927 |  |  | $ | 213,392 |
Supplemental Cash Flow Information: |  |  |  |  |  |  |  |
Interest Paid |  | $ | 222,765 |  |  | $ | 670,165 |
Supplemental disclosure of non-cash investing and financing activities: |  |  |  |  |  |  |  |
Debt financing costs booked in equity |  | $ | - |  |  | $ | 676,822 |
Stock issued for acquisitions |  | $ | 2,000,000 |  |  | $ | 155,000 |
PPP Loan Forgiveness |  | $ | 1,032,316 |  |  | $ | - |
Operating lease right of use assets and liabilities extension |  | $ | 632,725 |  |  | $ |  |

See accompanying notes to unaudited condensed consolidated financial statements

8

urban-gro, Inc.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1 – ORGANIZATION AND ACQUISITIONS, BUSINESS PLAN, AND LIQUIDITY

Organization

urban-gro, Inc. and its direct and indirect wholly owned subsidiaries (collectively, the “Companies”) (“we,” “us,” “our,” the “Company,” or “urban-gro”) is a leading architectural, engineering, consulting and design services company focused on the sustainable commercial indoor horticulture market. To serve our horticulture clients, we engineer and design indoor controlled environment agriculture (“CEA”) facilities and then integrate complex environmental equipment systems into those facilities. Through this work, we create high-performance indoor cultivation facilities for our clients to grow specialty crops, including leafy greens, vegetables, herbs, and plant-based medicines. Our custom-tailored approach to design, procurement, and equipment integration provides a single point of accountability across all aspects of indoor growing operations. We also help our clients achieve operational efficiency and economic advantages through a full spectrum of professional services and programs focused on facility optimization and environmental health which establish facilities that allow clients to manage, operate and perform at the highest level throughout their entire cultivation lifecycle once they are up and running. We also serve a broad range of commercial and governmental entities, providing them with planning, consulting, architectural and engineering design services for their facilities.

We aim to work with our clients from inception of their project in a way that provides value throughout the life of their facility. We are a trusted partner and advisor to our clients and offer a complete set of engineering and managed services complemented by a vetted suite of select cultivation equipment systems.

Acquisitions

On June 28, 2021, urban-gro, Inc., (the “Company” or “Parent”), urban-gro Architect Holdings, LLC, (the “Buyer”), a wholly-owned subsidiary of the Company, the 2WRCO Shareholders, the 2WRGA Shareholders, the MJ12 Shareholders, the 2WRMS Shareholders (collectively, the “Sellers” and each a “Seller”), and Sam Andras, an individual (the “Seller Representative”) entered into a Stock Purchase Agreement (the “Purchase Agreement”), pursuant to which the Buyer would purchase all of the issued and outstanding capital stock of 2WR of Colorado, Inc., a Colorado corporation (“2WRCO”), 2WR of Georgia, Inc., a Georgia corporation (“2WRGA”), MJ12 Design Studio, Inc., a Colorado corporation (“MJ12”) (collectively, the “Purchased Shares”) from the Sellers. In connection with the acquisition of the Purchased Shares, Buyer would enter into an affiliate relationship with 2WR of Mississippi, P.C., a Mississippi professional corporation (“2WRMS” and together with 2WRCO, 2WRGA and MJ12, the “Target Companies”).

Pursuant to the Purchase Agreement, the Purchased Shares had an initial purchase price of up to $7.1 million, which purchase price is subject to customary working capital adjustments (the “Purchase Price”). At closing, the Purchase Price was paid in the form of wire transfer of immediately available funds and the issuance of unregistered shares (the “Closing Payment Shares”) of Parent’s common stock, par value $0.001 (“Parent Common Stock”), which Closing Payment Shares had an aggregate stated value of $2.0 million. Additionally, the Purchase Agreement provides for additional earnout payments (“Earnout Payments”) to the Sellers of up to an aggregate amount of $2.0 million, payable in cash or unregistered shares of Parent Common Stock in the Buyer’s sole discretion. The Earnout Payments are payable quarterly for a two-year period and will be equal to twenty percent of the Target Companies’ Quarterly Gross Profit (as defined in the Purchase Agreement). The value of the shares of Parent Common Stock issued in the transaction was determined based upon the daily volume weighted average closing price of the Parent Common Stock in the ten trading days prior to the issuance of such shares. The Company accounted for the initial acquisition of the Target Companies as follows:

SCHEDULE OF INITIAL ACQUISITION OF TARGET COMPANIES

Purchase Price |  | $ | 10,058,536 |
Allocation of Purchase Price: |  |  |  |
Cash |  | $ | 943,894 |
Accounts receivable, net |  | $ | 1,597,341 |
Prepayments and other assets |  | $ | 71,936 |
PPE, net |  | $ | 63,246 |
Goodwill |  | $ | 7,990,980 |
Intangible assets |  | $ | 1,763,000 |
Accrued expenses |  | $ | 1,931,111 |
Deferred tax liability |  | $ | 440,750 |

The following table summarizes the supplemental information on an unaudited pro forma basis, as if the acquisition had been consummated as of January 1, 2020:

SCHEDULE OF SUPPLEMENTAL INFORMATION ON UNAUDITED PRO-FORMA BASIC OF ACQUISITION

|  | 2021 |  |  | 2020 |  |  | 2021 |  |  | 2020 |
|  | Three Months Ended September 30, |  |  | Nine Months Ended September 30, |
|  | 2021 |  |  | 2020 |  |  | 2021 |  |  | 2020 |
Revenues |  |  | 19,225,173 |  |  |  | 9,600,989 |  |  |  | 47,842,906 |  |  |  | 21,036,536 |
Net income (loss) |  |  | 389,217 |  |  |  | (655,831 | ) |  |  | 1,022,095 |  |  |  | (3,490,989 | )

These amounts have been calculated after applying the Company’s accounting policies and adjusting the results of the acquisitions to reflect the additional amortization of intangibles and the purchase price adjustments as if they had been applied on January 1, 2020.

Basis of Presentation

These consolidated financial statements are presented in United States dollars and have been prepared in accordance with United States generally accepted accounting principles (“GAAP”). On December 31, 2020, we effected a 1-for-6 reverse stock split with respect to our common stock. All share and per share information in these consolidated financial statements gives effect to this reverse stock split, including restating prior period reported amounts. On July 30, 2021, we acquired 2WR of Colorado, Inc., 2WR of Georgia, Inc. and MJ12 Design Studio, Inc., entities that had common ownership and management. We have accounted for the business combination by applying the acquisition method of accounting (ASC 805-10-25).

Liquidity and Going Concern

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates realization of assets and the satisfaction of liabilities in the normal course of business within one year after the date the consolidated financial statements are available to be issued.

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Unaudited Condensed Consolidated Financial Statements

The Company has prepared the accompanying condensed consolidated financial statements pursuant to the rules and regulations of the SEC for condensed financial reporting. The condensed consolidated financial statements are unaudited and, in the Company’s opinion, include all adjustments, consisting of normal recurring adjustments and accruals necessary for a fair presentation of the Company’s condensed consolidated balance sheets, condensed consolidated statements of operations and comprehensive income (loss), condensed consolidated statements of shareholders’ equity (deficit) and condensed consolidated statements of cash flows for the periods presented. The results reported in these condensed consolidated financial statements should not be regarded as necessarily indicative of results that may be expected for the entire year. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been omitted in accordance with regulations of the SEC. These condensed consolidated financial statements should be read in conjunction with the financial statements and notes thereto included in the Company’s consolidated financial statements in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020.

Significant Accounting Policies

For a detailed discussion about the Company’s significant accounting policies, refer to Note 2 — “Summary of Significant Accounting Policies,” in the Company’s consolidated financial statements included in the Company’s 2020 Form 10-K. During the nine months ended September 30, 2021, there were no material changes made to the Company’s significant accounting policies.

9

Use of Estimates

In preparing condensed consolidated financial statements in conformity with GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of assets and liabilities at the date of the condensed consolidated financial statements and revenues and expenses during the reported period. Actual results could differ from those estimates. Significant estimates include: estimated revenues earned under design contracts; estimated useful lives and potential impairment of long-lived assets, intangibles and goodwill; inventory write offs; allowance for deferred tax assets; and allowance for bad debt.

Reclassification

Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.

Business Combinations

Acquisitions of businesses are accounted for using the acquisition method. The consideration transferred in a business combination is measured at fair value, which is calculated as the sum of the acquisition date fair values of the assets transferred, liabilities incurred to the former owners of the acquired entities and the equity interests issued in exchange for control of the acquired entities. Acquisition related costs are recognized in net income (loss) as incurred.

Recently Issued Accounting Pronouncements

From time to time, the Financial Accounting Standards Board (the “FASB”) or other standards setting bodies issue new accounting pronouncements. The FASB issues updates to new accounting pronouncements through the issuance of an Accounting Standards Update (“ASU”). Unless otherwise discussed, the Company believes that the impact of recently issued guidance, whether adopted or to be adopted in the future, is not expected to have a material impact on the Company’s financial statements upon adoption.

NOTE 3 – RELATED PARTY TRANSACTIONS

Cloud 9 Support, LLC (“Cloud 9”), a company owned by James Lowe, a director and shareholder, purchases materials from the Company. Total sales to Cloud 9 from the Company were $99,556 and $359,562 for the nine months ended September 30, 2021, and 2020, respectively, and $5,349 and $112,405 during the three months ended September 30, 2021 and 2020, respectively. Outstanding receivables from Cloud 9 as of September 30, 2021 and December 31, 2020 totaled $10,975 and $61,678, respectively.

In October 2018, we issued a $1,000,000 unsecured note payable to Cloud 9, which originally became due April 30, 2019 (the “Cloud 9 Note”). The Cloud 9 Note was personally guaranteed by Bradley Nattrass, our Chief Executive Officer, and Octavio Gutierrez, a co-founder of the Company. The Cloud 9 Note had a one-time origination fee of $12,500. Interest accrued at the rate of 12% per annum and was paid monthly. As additional consideration for the Cloud 9 Note, we granted Mr. Lowe (as designee of Cloud 9) an option to purchase 5,000 shares of our common stock at an exercise price of $7.20 per share, which option is exercisable for a period of five years. The due date for the Cloud 9 Note was extended in May 2019 to December 31, 2019 and the interest rate was decreased to 9% per year. In consideration for Cloud 9 extending the maturity date of the note and reducing the interest rate, we issued 1,667 shares of our common stock to Mr. Lowe (as designee of Cloud 9).

On February 21, 2020, we entered into an agreement to amend the Cloud 9 Note to extend the maturity date therein from December 31, 2019 to the date which is the earlier of 60 days following the date: (a) on which demand for repayment is made by the lenders under the Credit Agreement, as described in Note 9; or (b) the maturity date under the Credit Agreement.

In addition, on February 25, 2020, the Company entered into a subordination, postponement and standstill agreement with Cloud 9 (the “Subordination Agreement”) pursuant to which Cloud 9 agreed to postpone and subordinate all payments due under the promissory note until the facilities under the Credit Agreement have been fully and finally repaid. The term for the Subordination Agreement continued in force as long as the Company was indebted to the agent or lenders under the Credit Agreement. In consideration for Cloud 9’s agreement to extend the maturity date of the promissory note and to enter into the Subordination Agreement, we issued 16,667 shares of common stock to Mr. Lowe (as designee of Cloud 9).

On December 15, 2020, Mr. Lowe agreed to convert the $1,000,000 Cloud 9 Note plus $4,500 of accrued interest into a convertible note bridge financing (the “James Lowe Note”) (see “Bridge Financing” in Note 8 – Notes Payable). The James Lowe Note carried interest at the rate of 12% and a maturity date of December 31, 2021. The James Lowe Note plus accrued interest was mandatorily converted into 137,940 shares of our common stock on February 17, 2021 in connection with the other Bridge Financing notes.

The Company follows ASC 850, Related Party Disclosures, for the identification of related parties and disclosure of related party transactions.

In accordance with ASC 850, the Company’s combined financial statements include disclosures of material related party transactions, other than compensation arrangements, expense reimbursements, and other similar items in the ordinary course of business, as well as transactions that are eliminated in the preparation of the combined financial statements.

NOTE 4 – PREPAYMENTS AND OTHER ASSETS

Prepayments and other assets are comprised of prepayments paid to vendors to initiate orders and prepaid services and fees. The prepaid balances are summarized as follows:

SCHEDULE OF PREPAID BALANCES

|  | September 30, 2021 |  |  | December 31, 2020 |
Vendor prepayments |  | $ | 6,750,228 |  |  | $ | 2,676,493 |
Prepaid services and fees |  |  | 1,036,640 |  |  |  | 365,931 |
Deferred financing asset (See Note 9 - Debt) |  |  | - |  |  |  | 504,644 |
Other assets |  |  | 3,769 |  |  |  | - |
Prepayments and other assets |  | $ | 7,790,637 |  |  | $ | 3,547,068 |

10

NOTE 5 – INVESTMENTS

The Company has a strategic investment in Edyza, Inc. (“Edyza”), a hardware and software technology company that enables dense sensor networks in agriculture, healthcare, and other environments that require precise micro-climate monitoring. The Company measures this investment at cost, less any impairment changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer. The balance as of September 30, 2021 and December 31, 2020 was $1,710,358.

NOTE 6 – GOODWILL & INTANGIBLE ASSETS

Goodwill

The Company recorded goodwill in conjunction with the initial acquisition of Impact Engineering, Inc. (“Impact”) on March 7, 2019 and 2WR Colorado, Inc, 2WR Georgia, Inc. and MJ12 Design Studio, Inc. on July 30, 2021. The goodwill balance as of September 30, 2021 and December 31, 2020 is $8,893,047 and 902,067, respectively. Goodwill is not amortized. There is no goodwill for income tax purposes. The Company did not record any impairment charges related to goodwill for the periods ended September 30, 2021 and 2020.

Intangible Assets Other Than Goodwill

Finite-lived intangible assets as of September 30, 2021 and December 31, 2020 consisted of the following:

SCHEDULE OF FINITE-LIVED INTANGIBLE ASSETS

|  | September 30, 2021 |
|  | Cost |  |  | Accumulated Amortization |  |  | Net Book Value |
Customer relationships |  |  | 834,000 |  |  |  | 18,905 |  |  |  | 815,095 |
Trademarks and trade names |  |  | 499,000 |  |  |  | 14,333 |  |  |  | 484,667 |
Backlog and Other |  |  | 519,004 |  |  |  | 72,979 |  |  |  | 446,025 |
|  |  | 1,852,004 |  |  |  | 106,217 |  |  |  | 1,745,787 |

|  | December 31, 2020 |
|  | Cost |  |  | Accumulated Amortization |  |  | Net Book Value |
Other |  |  | 89,004 |  |  |  | 4,490 |  |  |  | 84,514 |
|  |  | 89,004 |  |  |  | 4,490 |  |  |  | 84,514 |

Amortization expense for intangible assets for the nine months ended September 30, 2021 and 2020 was $101,727 and $1,228, respectively. Amortization expense for intangible assets for the three months ended September 30, 2021 and 2020 was $101,149 and $409, respectively.

NOTE 7 – ACCRUED EXPENSES

Accrued expenses are summarized as follows:

SCHEDULE OF ACCRUED EXPENSES

|  | September 30, |  |  | December 31, |
|  | 2021 |  |  | 2020 |
Accrued operating expenses |  | $ | 2,181,208 |  |  | $ | 717,503 |
Accrued wages and related expenses |  |  | 1,422,633 |  |  |  | 408,907 |
Accrued interest expense |  |  | - |  |  |  | 99,258 |
Accrued sales tax payable |  |  | 661,998 |  |  |  | 572,826 |
Accrued expenses |  | $ | 4,265,839 |  |  | $ | 1,798,494 |

Accrued sales tax payable is comprised of amounts due to various states and Canadian provinces for 2015 through 2020.

NOTE 8 – NOTES PAYABLE

The following is a summary of notes payable excluding related party notes payable:

SCHEDULE OF NOTES PAYABLE

|  | September 30, |  |  | December 31, |
|  | 2021 |  |  | 2020 |
Paycheck Protection Program (“PPP”) loan entered into on April 16, 2020. The Company applied for and has been notified that the full amount of the loan, which was used for eligible expenditures for payroll and other expenses described in the CARES Act was forgiven on June 11, 2021. |  | $ | - |  |  |  | 1,020,600 |
Convertible notes related to bridge financing. See Bridge Financing Notes below. |  |  | - |  |  |  | 1,854,500 |
Total |  |  | - |  |  |  | 2,875,100 |
Less current maturities |  |  | - |  |  |  | (1,854,500 | )
Long Term |  | $ | - |  |  | $ | 1,020,600 |

During the fourth quarter of 2020 the Company entered into bridge financing notes (the “Bridge Financing Notes”) totaling $1,854,500. The Bridge Financing Notes are a combination of $1,004,500 in the James Lowe Note (See Note 3 – Related Party Transactions), $350,000 received in November 2020, and an additional $500,000 received in December 2020. The Bridge Financing Notes carried interest at the rate of 12% and had a maturity date of December 31, 2021. The Bridge Financing Notes were mandatorily convertible upon the closing of a sale of the securities of the Company, whether in a private placement or pursuant to an effective registration statement under the Securities Act, resulting in at least $2,500,000 of gross proceeds to the Company (a “Qualified Offering”). In the event of a Qualified Offering, the outstanding principal and interest of the Bridge Financing Notes were to be converted into the identical security issued at such Qualified Offering at 75% of the per security price paid by investors in connection with the Qualified Offering. The Offering described in Note 12 – Shareholders Equity, was a Qualified Offering and the Bridge Financing Notes were converted into equity in connection with the Offering on February 17, 2021.

11

NOTE 9 – DEBT

The Company’s borrowings as of September 30, 2021 and December 31, 2020 consisted of the following:

SCHEDULE OF DEBT

|  | September 30, |  |  | December 31, |
|  | 2021 |  |  | 2020 |
Revolving Facility |  | $ | - |  |  | $ | 3,403,143 |
Term Loan, net of unamortized debt issuance costs |  |  | - |  |  |  | 1,868,320 |
Total |  |  | - |  |  |  | 5,271,463 |
Less current debt due within one year |  |  | - |  |  |  | (5,271,463 | )
Total long-term debt |  | $ | - |  |  | $ | - |

On February 21, 2020, we entered into a letter agreement (the “Credit Agreement”) by and among the Company, as borrower, urban-gro Canada Technologies Inc. and Impact., as guarantors, the lenders party thereto (the “Lenders”), and Bridging Finance Inc., as administrative agent for the Lenders (the “Agent”). The Credit Agreement, which was denominated in Canadian dollars (C$), was comprised of (i) a 12-month senior secured demand term loan facility in the amount of C$2.7 million ($2.0 million), which was funded in its entirety on the closing date (the “Term Loan”); and (ii) a 12-month demand revolving credit facility of up to C$5.4 million ($4.0 million), which could be drawn from time to time, subject to the terms and conditions set forth in the Credit Agreement and described further below (the “Revolving Facility,” and together with the Term Loan, the “Facilities”). The Credit Agreement was personally guaranteed by the Company’s CEO and Chairman, Brad Nattrass, and was to be in place for the original term of the Credit Agreement (1 year) plus a 1-year extension period at the discretion of the Lender as provided in the Credit Agreement.

The final maturity date of the Facilities was initially stipulated in the Credit Agreement as the earlier of (i) demand, and (ii) the date that is 12 months after the closing date, with a potential extension to the date that is 24 months after the closing date (the “Initial Maturity Date”). The Facilities bore interest at the annual rate established and designated by the Bank of Nova Scotia as the prime rate, plus 11% per annum. Accrued interest on the outstanding principal amount of the Facilities was due and payable monthly in arrears, on the last business day of each month, and on the Initial Maturity Date.

The Revolving Facility could initially be borrowed and re-borrowed on a revolving basis by the Company during the term of the Facilities, provided that borrowings under the Revolving Facility were limited by a loan availability formula equal to the sum of (i) 90% of insured accounts receivable, (ii) 85% of investment grade receivables, (iii) 75% of other accounts receivable, (iv) 50% of eligible inventory, and (v) the lesser of C$4.05 million ($3.0 million) and (A) 75% of uncollected amounts on eligible signed equipment orders for equipment systems contracts and (B) 85% of uncollected amounts on eligible signed professional services order forms for design contracts. The Revolving Facility could be prepaid in part or in full without a penalty at any time during the term of the Facilities, and the Term Loan could be prepaid in full or in part without penalty subject to 60 days prior notice in each case subject to certain customary conditions.

On September 4, 2020, the Company executed an amendment to the Credit Agreement (the “First Amendment”) whereas the Facilities described above were due on December 31, 2021 (the “Revised Maturity Date”). The First Amendment also increased the rate at which the Facilities would bear interest to the annual rate established and designated by the Bank of Nova Scotia as the prime rate, plus 12% per annum.

As a result of the First Amendment, the Company was required to prepay, on or before January 31, 2021, $1,000,000 of the balance of the Term Loan and begin making monthly payments of $100,000 on the balance on the Term Loan starting on March 1, 2021. Additionally, the Company was required to make monthly payments of $50,000 on the balance under the Revolving Facility beginning October 1, 2020 and could make no more draws under the Revolving Facility.

The Company incurred $1,314,868 of debt issuance costs in connection with these Facilities, of which $676,822 was non-cash in the form of Common Stock and warrant issuances. The Company estimated the fair value of these warrants at the respective balance sheet dates using the Black-Scholes option pricing based on the market value of the underlying Common Stock at the valuation measurement date of $6.00, the remaining contractual terms of the warrants of 5 years, risk free interest rate of 1.14% an expected volatility of the price of the underlying Common Stock of 100%. The Company recorded the debt issuance costs as either a deferred financing asset or a direct reduction of the loan obligation based on the pro-rata value of the Revolving Facility and Term Loan, respectively, on the closing date. The debt issuance costs were being amortized as interest expense over the life of the Facilities, until the Revised Maturity Date. On February 17, 2021, the Company repaid all amounts outstanding under the Credit Agreement and expensed the remaining unamortized debt issuance costs as loss on extinguishment of debt. As of December 31, 2020, there were $504,644 and $252,322 of unamortized debt issuance costs remaining related to the Revolving Facility and Term Loan, respectively.

NOTE 10 – RISKS AND UNCERTAINTIES

Concentration Risk

During the nine months ended September 30, 2021 one client represented 51% of total revenue, compared to the nine months ended September 30, 2020 where a separate client represented 26% of total revenue. During the three months ended September 30, 2021, one client represented 58% of total revenue, compared to the three months ended September 30, 2020, where a separate client represented 51% of total revenue. At September 30, 2021 one client represented 64% of total outstanding accounts receivable. At December 31, 2020, that same client represented 23% and a separate client represented 17% of total outstanding accounts receivable.

12

During the nine months ended September 30, 2021, 15% of the Company’s total purchases were from one vendor compared to 27% from another vendor for the nine months ended September 30, 2020. During the three months ended September 30, 2021, one vendor represented 18% of the Company’s total purchases, compared to the three months ended September 30, 2020, where a separate vendor represented 48% of the Company’s total purchases. At September 30, 2021, one vendor represented 41% of total accounts payable. At December 31, 2020, a separate vendor represented 25% of total accounts payable.

Coronavirus Pandemic

The outbreak of COVID-19, a novel strain of coronavirus first identified in China, which has spread across the globe including the U.S., has had an adverse impact on our operations and financial condition. The response to this coronavirus by federal, state and local governments in the U.S. has resulted in significant market and business disruptions across many industries and affecting businesses of all sizes. This pandemic has also caused significant stock market volatility and further tightened capital access for most businesses. Given that the COVID-19 pandemic and its disruptions are of an unknown duration, they could have an adverse effect on our liquidity and profitability.

The ultimate magnitude of COVID-19, including the extent of its impact on our financial and operational results, which could be material, will depend on the length of time that the pandemic continues, its effect on the demand for our products and our supply chain, the effect of governmental regulations imposed in response to the pandemic, as well as uncertainty regarding all of the foregoing. We cannot at this time predict the full impact of the COVID-19 pandemic, but it could have a larger material adverse effect on our business, financial condition, results of operations and cash flows beyond what is discussed within this Report.

NOTE 11 – STOCK-BASED COMPENSATION

Stock-based compensation expense for the nine months ended September 30, 2021 and 2020 was $1,096,441 and $1,391,807, respectively, based on the vesting schedule of the stock grants and options. Stock based compensation expense for the three months ended September 30, 2021 and 2020 was $506,034 and $399,258, respectively, based on the vesting schedule of the stock grants and options. No cash flow effects are anticipated for stock grants.

Stock Grants:

The following table shows stock grant activity for the nine months ended September 30, 2021:

SCHEDULE OF STOCK GRANT ACTIVITY

G |  |  | 2021 |
Grants outstanding as of December 31, 2020 |  |  | 118,889 |
Grants awarded |  |  | 101,102 |
Grants Vested |  |  | 16,667 |
Grants outstanding as of September 30, 2021 |  |  | 203,324 |

As of September 30, 2021, the Company has $620,811 in unrecognized share-based compensation expense related to these stock grants.

Stock Options:

The following table shows stock option activity for the nine months ended September 30, 2021:

SCHEDULE OF STOCK OPTION ACTIVITY

|  | Number of Shares |  |  | Weighted Average Remaining Life (Years) |  |  | Weighted Average Exercise Price |
Stock options outstanding as of December 31, 2020 |  |  | 638,278 |  |  |  | 7.72 |  |  | $ | 6.48 |
Issued |  |  | 55,833 |  |  |  | 4.51 |  |  | $ | 6.00 |
Expired |  |  | (18,444 | ) |  |  | - |  |  | $ | 7.89 |
Exercised |  |  | (4,777 | ) |  |  | - |  |  | $ | 6.78 |
Stock options outstanding as of September 30, 2021 |  |  | 670,890 |  |  |  | 7.55 |  |  | $ | 6.40 |
Stock options exercisable as of September 30, 2021 |  |  | 404,140 |  |  |  | 7.69 |  |  | $ | 6.46 |

The fair value of the stock options is calculated using the Black-Scholes pricing model based on the market value of the underlying common stock at the valuation measurement date of $9.39, the remaining contractual term of the options of 5 years, risk-free interest rate of 1.61% and expected volatility of the price of the underlying common stock of 100%.

As of September 30, 2021, the Company has $368,061 in unrecognized share-based compensation expense related to these stock options. The aggregate intrinsic value of the options outstanding and exercisable as of September 30, 2021 is $0.

NOTE 12 – SHAREHOLDERS’ EQUITY

In March 2020, an executive left the Company and returned 16,667 common shares as part of the related separation agreement. The Company retired the shares and reduced its issued and outstanding stock by 16,667 shares.

13

On February 17, 2021, we completed an offering of 6,210,000 shares of our common stock, inclusive of the underwriters full overallotment, at $10.00 per share for total gross offering proceeds of $62,100,000. In connection with this offering, we received approval to list our common stock on the Nasdaq Capital Market under the symbol “UGRO”.

On May 24, 2021, we announced that the Board of Directors authorized a stock repurchase program to purchase up to $5.0 million of the currently outstanding shares of the Company’s common stock, over a period of 12 months through open market purchases, in compliance with Rule 10b-18 under the Securities Exchange Act of 1934. Under this program, the Company has repurchased 421,024 shares of common stock at an average price per share of $9.33, for a total price of $3,926,811 during the nine months ended September 30, 2021. In total, the Company has repurchased 771,024 shares of common stock at an average price per share of $8.95 for a total of $6,901,811 during the nine months ended of September 30, 2021.

NOTE 13 – WARRANTS

The following table shows warrant activity for the nine months ended September 30, 2021.

SCHEDULE OF WARRANT ACTIVITY

|  | Number of shares |  |  | Weighted Average Exercise Price |
Warrants outstanding as of December 31, 2020 |  |  | 202,752 |  |  | $ | 13.64 |
Exercised |  |  | (22,490 | ) |  | $ | 14.94 |
Issued in connection with equity offering |  |  | 310,500 |  |  | $ | 12.50 |
Expired |  |  | (116,674 | ) |  | $ | 18.00 |
Warrants outstanding as of September 30, 2021 |  |  | 374,088 |  |  | $ | 11.26 |
Warrants exercisable as of September 30, 2021 |  |  | 374,088 |  |  | $ | 11.26 |

The fair value of the warrants issued in connection with the equity offering were calculated using the Black-Scholes pricing model based on the market value of the underlying common stock at the valuation measurement date of $10.00, the remaining contractual term of the options of 5 years, risk-free interest rate of .57% and expected volatility of the price of the underlying common stock of 100%.

The weighted-average life of the warrants is 1.95 years. The aggregate intrinsic value of the warrants outstanding and exercisable as of September 30, 2021 is $0.

NOTE 14 – SUBSEQUENT EVENTS

The Company has evaluated events and transaction occurring subsequent to September 30, 2021 up to the date of this filing of these condensed consolidated financial statements. These statements contain all necessary adjustments and disclosures resulting from that evaluation.

On October 13, 2021, the Company learned that an unauthorized third party initiated fraudulent wire transfers of approximately $5,100,000 from the Company’s accounts. Approximately $0.8 million is in the process of being recovered from the recipient banks. The Company has reported the incident to its insurer and expects the Company’s bank, the bank’s insurers or the Company’s insurer to reimburse the Company for the remaining balance, as the Company believes the bank failed to follow proper and industry standard procedures designed to prevent such a theft and is therefore liable for the unrecovered balance.

On October 30, 2021, the Company participated in a convertible note offering of Xtraction Services, Inc., a/k/a XS Financial Inc. (CSE: XSF) (OTCQB: XSHLF) (“XSF”), a specialty finance company providing CAPEX financing solutions, including equipment leasing, to Controlled Environment Agriculture (CEA) companies in the United States. The Company invested $2,500,000 and the total raise by XSF was $43,500,000.

14

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion should be read in conjunction with our condensed consolidated financial statements and notes thereto included herein. See also “Forward Looking Statements” on page 3 of this Report.

Overview and History

urban-gro, Inc. (“we,” “us,” “our,” the “Company,” or “urban-gro”) is a leading architectural, engineering and cultivation design services company focused on the sustainable commercial indoor horticulture market. On July 30, 2021, we acquired three architecture design firms (2WR Colorado, Inc, 2WR Georgia, Inc. and MJ12 Design Studios, Inc., collectively the “2WR Entities”) from their shareholders. The 2WR Entities were under common ownership and management. Effective March 7, 2019, we acquired a mechanical, electrical and plumbing engineering services firm (Impact Engineering, Inc. (“Impact”)) from its sole shareholder. We engineer and design indoor controlled environment agriculture (“CEA”) facilities and then integrate complex environmental equipment systems into those facilities. Through this work, we create high-performance indoor cultivation facilities for our clients to grow specialty crops, including leafy greens, vegetables, herbs, and plant-based medicines. Our custom-tailored approach to design, procurement, and equipment integration provides a single point of accountability across all aspects of indoor growing operations. We also help our clients achieve operational efficiency and economic advantages through a full spectrum of professional services and programs focused on facility optimization and environmental health which establish facilities that allow clients to manage, operate and perform at the highest level throughout their entire cultivation lifecycle once they are up and running.

We aim to work with our clients from inception of their project in a way that provides value throughout the life of their facility. We are a trusted partner and advisor to our clients and offer a complete set of engineering and managed services complemented by a vetted suite of select cultivation equipment systems. Outlined below is an example of a complete project with estimated time frames for each phase that demonstrate how we provide value to our clients for the life of their facility.

15

Our indoor commercial cultivation solution offers an integrated suite of services and equipment systems that generally fall within the following categories:

| ● | Service Solutions:

| ● | Architecture, Engineering Design Services – A comprehensive triad of services including:

| i. | Architecture
| ii. | Cultivation Space Programming (“CSP”)
| iii. | Integrated Cultivation Design (“ICD”)
| iv. | Full-Facility Mechanical, Electrical, and Plumbing (“MEP”)

| ● | gro-care® - A recurring revenue subscription-based managed service offering including:

| i. | Remote Monitoring, Reporting, Support, and Training Services
| ii. | Facility and Equipment Commissioning & Audit Services
| iii. | Environmental Sciences Groups’ (“ESG”) Compliance and Program Services

| ● | Integrated Equipment Solutions:

| ● | Design, Source, and Integration of Complex Environmental Equipment Systems Including Purpose-Built Heating, Ventilation, and Air Conditioning (“HVAC”) solutions, Environmental Controls, Fertigation, and Irrigation Distribution.
| ● | Value-Added Reselling (“VAR”) of Cultivation Equipment including a Complete line of Lighting, Fans and Rolling Benching Systems
| ● | Strategic Vendor Relationships with Premier Manufacturers

The majority of our clients are commercial CEA cultivators. We believe one of the key points of our differentiation that our clients value is the depth of experience of our employees and our Company. We currently employ 75 individuals. Approximately two-thirds of our employees are considered experts in their areas of focus, and our team includes Architects, Engineers (Mechanical, Electrical, Plumbing, Controls, and Agricultural), Professional Engineers, horticulturalists and individuals with Masters Degrees in Plant Science and Business Administration. As a company, we have worked on more than 450 indoor CEA facilities, and believe that the experience of our team and Company provides clients with the confidence that we will proactively keep them from making common costly mistakes during the build out and operational stages. Our expertise translates into clients saving time, money, and resources, and provides them ongoing access to expertise that they can leverage without having to add headcount to their own operations. We provide this experience in addition to offering a platform of the highest quality equipment systems that can be integrated holistically into our clients’ facilities.

Results Of Operations

Comparison of Results of Operations for the three months ended September 30, 2021 and 2020

During the three months ended September 30, 2021, we generated revenues of $18.3 million compared to revenues of $8.3 million during the three months ended September 30, 2020, an increase of $10.0 million, or 119%. Equipment systems revenue increased $9.1 million, primarily due to an increase in cultivation equipment sales, services revenue increased $1.0 million, primarily from the acquisition of the 2WR Entities, and consumable product sales decreased $0.1 million.

During the three months ended September 30, 2021, cost of revenues was $14.0 million compared to $6.7 million during the three months ended September 30, 2020, an increase of $7.3 million, or 111%. This increase is directly attributable to the increase in revenues indicated above.

Gross profit was $4.2 million (23% of revenues) during the three months ended September 30, 2021 compared to $1.7 million (20% of revenue) during the three months ended September 30, 2020. Gross profit as a percentage of revenues increased due to an increase in higher margin services revenues and higher margin equipment systems revenues for the comparable periods.

Operating expenses increased $2.3 million to $4.2 million for the three months ended September 30, 2021 compared to the three months ended September 30, 2020. This was due to a $2.2 million increase in general operating expenses, mainly due to an increase in salary and travel expenses, in part related to the acquisition of the 2WR Entities, and a $0.1 million increase in stock-based compensation expense.

Non-operating expense was $0.01 million for the three months ended September 30, 2021, compared to non-operating expenses of $0.5 million for the three months ended September 30, 2020. For the three months ended September 30, 2020, the Company incurred interest expense of $0.4 million and a purchase price contingent consideration expense of $0.1 million.

As a result of the above, we generated net income of $0.06 million for the three months ended September 30, 2021, or fully diluted net income per share of $0.00, compared to a net loss of $0.7 million for the three months ended September 30, 2020 or a fully diluted net loss per share of $0.14.

Comparison of Results of Operations for the nine months ended September 30, 2021 and 2020

During the nine months ended September 30, 2021, we generated revenues of $43.2 million compared to revenues of $16.6 million during the nine months ended September 30, 2020, an increase of $26.6 million, or 160%. Equipment systems revenue increased $26.3 million primarily due to an increase in cultivation equipment sales, services revenue increased $0.5 million, primarily from the acquisition of the 2WR Entities, and consumable product sales decreased $0.2 million.

During the nine months ended September 30, 2021, cost of revenues was $33.3 million compared to $12.6 million during the nine months ended September 30, 2020, an increase of $20.7 million, or 164%. This increase is directly attributable to the increase in revenues indicated above.

Gross profit was $9.8 million (23% of revenues) during the nine months ended September 30, 2021 compared to $4.0 million (24% of revenue) during the nine months ended September 30, 2020. Gross profit as a percentage of revenues decreased due primarily to an increase in lower margin equipment systems revenues for the comparable periods.

Operating expenses increased $2.9 million to $9.4 million for the nine months ended September 30, 2021 compared to the nine months ended September 30, 2020. This was due to a $3.2 million increase in general operating expenses, mainly due to an increase in salary and travel expenses, in part related to the acquisition of the 2WR Entities, offset by a $0.3 million reduction in stock-based compensation expense.

Non-operating expense was $0.7 million for the nine months ended September 30, 2021, compared to $1.5 million for the nine months ended September 30, 2020. The Company incurred a $1.0 million gain from the forgiveness of the PPP loan, an $0.8 million loss on the extinguishment of debt and interest expense of $0.9 million for the nine months ended September 30, 2021. For the nine months ended September 30, 2020, the company incurred interest expense of $1.0 million, recorded an impairment loss of $0.3 million related to an investment, and recorded $0.2 million in purchase price contingent consideration expense.

As a result of the above, we incurred net loss of $0.3 million for the nine months ended September 30, 2021, or a fully diluted net loss per share of ($0.03), compared to a net loss of $4.0 million for the nine months ended September 30, 2020 or a fully diluted net loss per share of ($0.83).

16

NON-GAAP FINANCIAL MEASURES

The Company uses the supplemental financial measure of Adjusted Earnings before Interest, Taxes, Depreciation and Amortization (“Adjusted EBITDA”) as a measure of our operating performance. Adjusted EBITDA is not calculated in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and it is not a substitute for other measures prescribed by GAAP such as net income (loss), income (loss) from operations, and cash flows from operating activities. We define Adjusted EBITDA as net income (loss) attributable to urban-gro, Inc., determined in accordance with GAAP, excluding the effects of certain operating and non-operating expenses including, but not limited to, interest expense, income taxes/benefit, depreciation of tangible assets, amortization of intangible assets, impairment of investments, unrealized exchange losses, debt forgiveness and extinguishment, stock-based compensation expense, and acquisition costs, that we do not believe reflect our core operating performance.

Our board of directors and management team focus on Adjusted EBITDA as a key performance and compensation measure. We believe that Adjusted EBITDA assists us in comparing our operating performance over various reporting periods because it removes from our operating results the impact of items that our management believes do not reflect our core operating performance.

The following table reconciles net loss attributable to the Company to Adjusted EBITDA for the periods presented:

|  | Three months Ended September 30, |  |  | Nine months Ended September 30, |
|  | 2021 |  |  | 2020 |  |  | 2021 |  |  | 2020 |
Net Income (Loss) |  | $ | 56,656 |  |  | $ | (694,281 | ) |  | $ | (271,482 | ) |  | $ | (3,959,882 | )
Interest expense |  |  | 4,331 |  |  |  | 393,158 |  |  |  | 326,397 |  |  |  | 1,057,501 |
Interest expense – BCF |  |  | – |  |  |  | – |  |  |  | 636,075 |  |  |  | – |
Impairment loss |  |  | – |  |  |  | – |  |  |  | – |  |  |  | 310,000 |
Loss on extinguishment of debt |  |  | – |  |  |  | – |  |  |  | 790,723 |  |  |  | – |
Stock-based compensation |  |  | 506,034 |  |  |  | 399,258 |  |  |  | 1,096,441 |  |  |  | 1,391,807 |
Contingent consideration - purchase price |  |  | – |  |  |  | 155,000 |  |  |  | – |  |  |  | 155,000 |
Impairment of investment |  |  | – |  |  |  | – |  |  |  | – |  |  |  | – |
Depreciation and amortization |  |  | 154,306 |  |  |  | 61,339 |  |  |  | 263,932 |  |  |  | 181,750 |
Acquisition costs |  |  | 141,052 |  |  |  | – |  |  |  | 198,609 |  |  |  | – |
One-time employee expenses |  |  | 125,000 |  |  |  | – |  |  |  | 125,000 |  |  |  | – |
PPP loan forgiveness |  |  | – |  |  |  | – |  |  |  | (1,032,316 | ) |  |  | – |
Adjusted EBITDA |  | $ | 990,379 |  |  | $ | 314,474 |  |  | $ | 2,133,379 |  |  | $ | (863,824 | )

As of December 31, 2020, the Company began reporting the dollar amount of contractually committed orders for equipment systems for which revenue has not been recognized (“Equipment Backlog”). As of September 30, 2021, the Company has also begun reporting the dollar amount of contractually committed orders for services revenue for which revenue has not been recognized (“Services Backlog” and collectively with Equipment Backlog, “Backlog”). Backlog is a non-GAAP financial measure that our board of directors and management team focus on as a key performance measure. Although there can be no assurances that Backlog will be recognized as equipment systems revenue in future periods, we believe that tracking Backlog assists us in estimating the timing of future equipment systems revenue. Backlog amounts, reported in millions of dollars, are reflected in the table below as of the dates indicated:

|  | December 31, 2020 |  |  | March 31, 2021 |  |  | June 30, 2021 |  |  | September 30, 2021 |
Equipment Backlog |  | $ | 14.6 |  |  | $ | 15.2 |  |  | $ | 27.9 |  |  | $ | 18.6 |
Services Backlog |  |  | NR |  |  |  | NR |  |  |  | NR |  |  | $ | 3.9 |
Backlog |  | $ | 14.6 |  |  | $ | 15.2 |  |  | $ | 27.9 |  |  | $ | 22.5 |

NR – Not reported

Liquidity and Capital Resources

As of September 30, 2021, we had cash of $40.5 million, which represented an increase of $40.3 million from December 31, 2020. This increase in cash and cash equivalents is primarily due to the net proceeds received from our equity offering in February of 2021 of $58.2 million offset by $5.8 million of debt repayment, $6.9 million of treasury stock purchases, and a $5.2 million decrease due to timing of deposits and prepayments to vendors during the nine months ended September 30, 2021.

Net cash provided by operating activities was $0.3 million during the nine months ended September 30, 2021, compared to net cash used in operating activities of $3.0 million during the nine months ended September 30, 2020, an improvement of $3.3 million. This increase in cash provided by operating activities is primarily the result of an improvement in income from operations for the comparable periods with the remaining fluctuation being primarily comprised of fluctuations in operating assets and liabilities. As of September 30, 2021, we had $9.4 million in client deposits related to client orders, compared to client deposits of $4.9 million as of December 31, 2020. We require prepayments from clients before any design work is commenced and before any material is ordered from the vendor. These prepayments are booked to the client deposits liability account when received. We expect client deposits to be relieved from the deposits account no longer than 12 months for each project. As of September 30, 2021, we had $7.8 million of vendor prepayments compared to $3.5 million as of December 31, 2020. As of September 30, 2021, we had $2.8 million in accounts payable, compared to $0.7 million as of December 31, 2020.

Net cash used in investing activities was $5.7 million for the nine months ended September 30, 2021, compared to $0.1 million during the nine months ended September 30, 2020. The Company used $5.6 million for the purchase of the 2WR Entities during the period. We have no material commitments for capital expenditures as of September 30, 2021

Net cash provided by financing activities was $45.7 million for the nine months ended September 30, 2021, compared to $2.9 million during the nine months ended September 30, 2020. Cash provided from financing activities during the nine months ended September 30, 2021 primarily relates to $58.4 million in net proceeds received from the issuance of stock, offset by $5.8 million used in the repayment of notes payable and $6.9 million in treasury shares acquired.

Inflation

Although our operations are influenced by general economic conditions, we do not believe that inflation had a material effect on our results of operations during the nine months ended September 30, 2021.

17

Critical Accounting Policies and Estimates

Critical Accounting Policies and Estimates

The discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires us to make estimates and judgments that affect the amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate our estimates based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions For a detailed discussion about the Company’s significant accounting policies, refer to Note 2 — “Summary of Significant Accounting Policies,” in the Company’s consolidated financial statements included in the Company’s 2020 Form 10-K. During the nine months ended September 30, 2021, there were no material changes made to the Company’s significant accounting policies.

Off-Balance Sheet Arrangements

We have not entered into any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources and would be considered material to investors.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

We are a smaller reporting company and are not required to provide the information under this Item pursuant to Regulation S-K.

ITEM 4. CONTROLS AND PROCEDURES.

Disclosure Controls and Procedures

Disclosure Controls and Procedures – Our management, with the participation of our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), has evaluated the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the period covered by this Report.

These controls are designed to ensure that information required to be disclosed in the reports we file or submit pursuant to the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and that such information is accumulated and communicated to our management, including our CEO and CFO to allow timely decisions regarding required disclosure.

Based on this evaluation, our CEO and CFO have concluded that our disclosure controls and procedures were effective as of September 30, 2021, at reasonable assurance levels.

We believe that our financial statements presented in this Form 10-Q fairly present, in all material respects, our financial position, results of operations, and cash flows for all periods presented herein.

Inherent Limitations – Our management team, including our CEO and CFO, does not expect that our disclosure controls and procedures will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. The design of any system of controls is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdown can occur because of simple error or mistake. In particular, many of our current processes rely upon manual reviews and processes to ensure that neither human error nor system weakness has resulted in erroneous reporting of financial data.

Changes in Internal Control over Financial Reporting – There were no changes in our internal control over financial reporting during our nine months ended September 30, 2021, which were identified in conjunction with management’s evaluation required by paragraph (d) of Rules 13a-15 and 15d-15 under the Exchange Act, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

18

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

The company has been sued in a putative breach of contract case in the District Court for Arapahoe County, CO. Crest Ventures, LLC v. urban-gro, Inc. (Case No. 2021CV31301 filed on July 30, 2021). The allegations in the action are based on a claim that Crest Ventures, LLC is entitled to commission compensation on the recent urban-gro, Inc. public stock offering. We believe we have substantial defenses to the claims asserted in this lawsuit and intend to vigorously defend this action.

The company has initiated an action against its former bank in the District Court for Boulder County, CO, urban-gro, Inc. v. Sunflower Bank, N.A. (Case No. 2021CV030829 filed on November 5, 2021). The action stems from the bank’s failure to properly follow security procedures and take steps necessary to identify, prevent, and/or remedy six (6) fraudulent wire transfers from urban-gro’s account, which ultimately resulted in a loss to urban-gro in the amount of $5,121,131.75. In so doing, the company claims the bank breached its duty of care owed to the company and as set forth in the Uniform Commercial Code. This breach resulted in damages to the company of the total loss plus other amounts to be determined by the court. The company believes that it will prevail and recover all missing funds.

To the best of our management’s knowledge and belief, there are no additional material claims that have been brought against us nor have there been any claims threatened.

ITEM 1A. RISK FACTORS

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information under this item.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURE

Not Applicable.

ITEM 5. OTHER INFORMATION

None.

ITEM 6. EXHIBITS

Exhibit No. |  | Description
10.1 |  | First Amendment to Loan Agreement, dated as of September 4, 2020, by and among the Registrant, urban-gro Canada Technologies Inc., Impact Engineering, Inc. and Bridging Finance Inc.
10.2 |  | Agreement, dated as of September 18, 2020, by and between the Registrant and George (Bob) Pullar.
31.1 |  | Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2 |  | Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32 |  | Certification of Chief Executive Officer and Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS |  | XBRL Instance Document
101.SCH |  | XBRL Schema Document
101.CAL |  | XBRL Calculation Linkbase Document
101.DEF |  | XBRL Definition Linkbase Document
101.LAB |  | XBRL Label Linkbase Document
101.PRE |  | XBRL Presentation Linkbase Document

19

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized, on November 9, 2021.

| URBAN-GRO, INC.
| By: | /s/ Bradley Nattrass
|  | Bradley Nattrass,
|  | Principal Executive Officer, a duly authorized officer
| By: | /s/ Richard Akright
|  | Richard A. Akright, Principal Financial Officer and Principal Accounting Officer

20